| 64.23 3.05 (4.99%) | 03-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 98.03 |
1-year : | 114.49 |
| Resists | First : | 83.93 |
Second : | 98.03 |
| Pivot price | 64.27 |
|||
| Supports | First : | 56.78 |
Second : | 40 |
| MAs | MA(5) : | 62.24  |
MA(20) : | 65.6 |
| MA(100) : | 80.45 |
MA(250) : | 64.69 |
|
| MACD | MACD : | -3.4 |
Signal : | -3.5 |
| %K %D | K(14,3) : | 61.7 |
D(3) : | 61.4 |
| RSI | RSI(14): 43.7 |
|||
| 52-week | High : | 99.5 | Low : | 30.81 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IRON ] has closed above bottom band by 49.5%. Bollinger Bands are 39.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 63.11 - 63.52 | 63.52 - 63.9 |
| Low: | 57.9 - 58.41 | 58.41 - 58.87 |
| Close: | 60.37 - 61.2 | 61.2 - 61.94 |
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Mon, 09 Mar 2026
IRON: Pivotal data for bitopertin in EPP expected Q4 2026; pipeline programs advance in anemia - TradingView
Sun, 08 Mar 2026
Disc Medicine (IRON) Is Down 8.2% After Wider 2025 Loss and ESOP Shelf Filing - Has The Bull Case Changed? - simplywall.st
Sat, 07 Mar 2026
Blue Owl Capital Holdings LP Sells 20,000 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Fri, 06 Mar 2026
Disc Medicine prices upsized securities offering to raise total $250M - MSN
Fri, 06 Mar 2026
Disc Medicine, Inc. $IRON Shares Acquired by Vanguard Group Inc. - MarketBeat
Wed, 04 Mar 2026
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 38 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 7.9 (%) |
| Held by Institutions | 104.3 (%) |
| Shares Short | 3,410 (K) |
| Shares Short P.Month | 4,280 (K) |
| EPS | -6.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.52 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -22.6 % |
| Return on Equity (ttm) | -35.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -6.16 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -180 (M) |
| Levered Free Cash Flow | -112 (M) |
| PE Ratio | -10.69 |
| PEG Ratio | 0 |
| Price to Book value | 3.29 |
| Price to Sales | 0 |
| Price to Cash Flow | -13.59 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|